Q32 Bio posted Q2 2026 results and updated its corporate outlook, offering investors a fresh view of its financial position and operating progress. The update f

Q32 Bio posted Q2 2026 results and updated its corporate outlook, offering investors a fresh view of its financial position and operating progress. The update follows earlier positive 36-week Phase 2a data for bempikibart in severe alopecia areata.